Design and Synthesis of Potent Bradykinin Agonists Containing a Benzothiazepine Moiety
Muriel Amblard, Isabelle Daffix, Philippe Bedos et al. · Journal of Medicinal Chemistry · 1999
A bradykinin analogue (H-Arg-Pro-Pro-Gly-Phe-Ser-D-BT-Arg-OH, 3) in which the Pro-Phe dipeptide was replaced by the (3S)[amino]-5-(carbonylmethyl)-2,3-dihydro-1, 5-benzothiazepin-4(5H)-one (D-BT) moiety has been synthesized. The same modification was performed on the potent bradykinin B(2) receptor antagonist HOE 140 (H-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH), in which the -D-Tic-Oic- moiety was replaced by D-BT to yield H-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-Arg-OH, 1 (JMV1116). These compounds were examined in vitro for their binding affinity toward bradykinin B(1) and B(2) receptors as well as for their ability to interfere with bradykinin-induced contraction of both human umbilical vein and rat uterus. The two compounds 3 and 1 competed with [(3)H]bradykinin binding to the human cloned B(2) receptor giving K(i) values of 13 +/- 2 and 0.7 +/- 0.1 nM, respectively. Unexpectedly, both compounds were full bradykinin B(2) receptor agonists on the human umbilical vein (pD(2) = 6.60 +/- 0.07 for 3 and 6.80 +/- 0.08 for 1) and rat uterus (pD(2) = 7.20 +/- 0.09 for 3 and 7.50 +/- 0.09 for 1) preparations with the same efficacy as bradykinin. In addition 1 induced a concentration-dependent phosphoinositide production in CHO cells expressing the human cloned B(2) receptor. These data provide evidence for a bioactive conformation of bradykinin constrained at the dipeptide Pro-Phe.
Cited by 62 works. doi:10.1021/jm9901529
Authors
- Muriel Amblard
- Isabelle Daffix
- Philippe Bedos
- Gilbert Bergé
- Didier Pruneau
- Jean‐Luc Paquet
- Jean‐Michel Luccarini
- Pierre Bélichard
- Pierre Dodey
- Jean Martínez
References
- Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides
- The Preparation of Merrifield‐Resins Through Total Esterification With Cesium Salts
- Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.
- Bioactive Conformation of Luteinizing Hormone-Releasing Hormone: Evidence from a Conformationally Constrained Analog
- Expression cloning of a human B1 bradykinin receptor.
- Infectious Diseases and Population Cycles of Forest Insects
- Bradykinin Antagonism Inhibits the Antigrowth Effect of Converting Enzyme Inhibition in the Dog Myocardium After Discrete Transmural Myocardial Necrosis
- Neuron atrophy during aging: programmed or sporadic?
- Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist
- Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors